|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,602.00 INR | +0.30% |
|
-1.01% | +1.73% |
| Jun. 02 | Alkem Laboratories Limited Launches Semaglutide in Single-Shot Pre-Filled Syringes At Price Starting Inr 350 | CI |
| Jun. 02 | Alkem Laboratories Shows Strong Moves But Weak Follow-Through |  |
| Market Cap | 670B 6.94B 6.09B 5.66B 5.21B 9.77B 9.95B 67.6B 26.38B 328B 26.03B 25.47B 1,137B | P/E 2026 |
27.5x | P/E 2027 * | 28.7x |
|---|---|---|---|---|---|
| Enterprise Value | 642B 6.64B 5.84B 5.43B 4.99B 9.36B 9.54B 64.76B 25.27B 314B 24.93B 24.4B 1,089B | EV / Sales 2026 |
4.3x | EV / Sales 2027 * | 3.92x |
| Free-Float |
37.56% | Yield 2026 |
1% | Yield 2027 * | 0.92% |
Last Transcript: Alkem Laboratories Limited
| 1 day | +0.30% | ||
| 1 week | -1.01% | ||
| Current month | +0.57% | ||
| 1 month | +4.38% | ||
| 3 months | -0.44% | ||
| 6 months | -2.72% | ||
| Current year | +1.73% |
| 1 week | 5,503 |  | 5,709 |
| 1 month | 5,394.5 | | 5,735.5 |
| Current year | 5,075 | | 5,933.5 |
| 1 year | 4,738.5 | | 5,933.5 |
| 3 years | 3,447 | | 6,439.9 |
| 5 years | 2,828 | | 6,439.9 |
| 10 years | 1,455 | | 6,439.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rajorshi Ganguli
PSD | President | - | - |
Akhilesh Sharma
PSD | President | - | - |
Nitin Agrawal
DFI | Director of Finance/CFO | - | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sandeep Singh
BRD | Director/Board Member | 44 | 2013-08-08 |
| Director/Board Member | 63 | 2008-02-10 | |
Sarvesh Singh
BRD | Director/Board Member | 44 | 2019-11-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.30% | -1.01% | +12.68% | +51.37% | 6.92B | |
| +1.97% | +2.53% | +52.73% | +156.66% | 1,037B | |
| +1.42% | +4.96% | +54.39% | +52.34% | 615B | |
| +1.43% | +5.25% | +37.31% | +78.74% | 448B | |
| +5.14% | +5.84% | +37.54% | +27.28% | 326B | |
| +1.85% | +4.64% | +38.53% | +39.87% | 293B | |
| -0.11% | +0.97% | +22.57% | +17.81% | 264B | |
| +0.25% | -3.10% | -24.44% | -42.25% | 216B | |
| +1.49% | +3.68% | +21.53% | +58.21% | 198B | |
| +0.40% | -0.64% | +18.78% | +62.28% | 162B | |
| Average | +0.78% | +0.88% | +27.16% | +50.23% | 356.44B | |
| Weighted average by Cap. | +0.51% | +1.47% | +38.28% | +75.19% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 146B 1.51B 1.33B 1.24B 1.14B 2.13B 2.17B 14.76B 5.76B 71.55B 5.68B 5.56B 248B | 165B 1.71B 1.5B 1.4B 1.29B 2.41B 2.46B 16.69B 6.51B 80.91B 6.43B 6.29B 281B |
| Net income | 25.13B 260M 229M 213M 195M 367M 373M 2.54B 990M 12.29B 976M 956M 42.65B | 23.59B 244M 215M 199M 183M 344M 351M 2.38B 929M 11.54B 917M 897M 40.04B |
| Net Debt | -28.13B -291M -256M -238M -219M -411M -418M -2.84B -1.11B -13.76B -1.09B -1.07B -47.75B | -21.73B -225M -198M -184M -169M -317M -323M -2.19B -856M -10.63B -845M -827M -36.89B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | ₹5,602.00 | +0.30% | 50,659 |
| 26-07-22 | ₹5,585.00 | -1.70% | 109,986 |
| 26-07-21 | ₹5,681.50 | +0.50% | 27,882 |
| 26-07-20 | ₹5,653.50 | +1.63% | 108,861 |
| 26-07-17 | ₹5,563.00 | -2.56% | 70,604 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALKEM Stock
Select your edition
All financial news and data tailored to specific country editions
